Most doctors are prisoners of their education and shackled by their profession.”
- Richard Diaz
A month ago we offered up the analysis below on this 'watch item' biotech stock from across the pond exclusively to Biotech Forum members. The stock is up over 40% since then but the concern is still intriguing. Today, we update our original thesis to account for all company-specific news and analyst ratings on this name since our original research was posted.
Company Overview:
Orchard Therapeutics (ORTX) is a London, United Kingdom-based biopharmaceutical company that IPO’d in